Thromb Haemost 1984; 52(03): 240-242
DOI: 10.1055/s-0038-1661187
Original Article
Schattauer GmbH Stuttgart

Fibrinogen, Factor VIII Related Antigen, Antithrombin III and α2-Antiplasmin in Peripheral Arterial Disease

M Christe
The Departement für Innere Medizin, Kantonsspital, Basel, Switzerland
,
A Delley
*   The Gerinnungs- und Fibrinolyselaboratorium, Zentrallaboratorium und Abteilung für Angiologie, Basel, Switzerland
,
G A Marbet
The Departement für Innere Medizin, Kantonsspital, Basel, Switzerland
,
L Biland
*   The Gerinnungs- und Fibrinolyselaboratorium, Zentrallaboratorium und Abteilung für Angiologie, Basel, Switzerland
,
F Duckert
The Departement für Innere Medizin, Kantonsspital, Basel, Switzerland
› Author Affiliations
Further Information

Publication History

Received 03 May 1984

Accepted 03 August 1984

Publication Date:
19 July 2018 (online)

Summary

In 306 subjects, 217 without and 89 with peripheral arterial disease (PAD), VIIIR:Ag and α2-antiplasmin are significantly higher in PAD (p < 0.01). In the PAD negative group the ratio α2-antiplasmin/antithrombin III activity is significantly higher 1.11 ± 0.3 in the patients with an abnormal exercise ECG typical of coronary disease than in normal subjects 1.02 ± 0.2 (p < 0.05). In the PAD positive group antithrombin III concentration is higher in patients with a normal exercise ECG than in patients with abnormal exercise ECG (p < 0.05). The same is true for α2- antiplasmin but not for the antithrombin III activity. Fibrinogen and VIIIR:Ag are higher in patients with a previous myocardial infarction, however, the age is also significantly different as compared to the group without previous myocardial infarction. Disturbance of the cerebral arterial circulation is characterized by an elevation of VIIIR:Ag and of α2-antiplasmin as comapred to the values obtained in patients without this complication. There is a general tendency towards higher α2-antiplasmin values with the extension of the arterial disease.

 
  • References

  • 1 Widmer LK, Stähelin HB, Nissen C, da Silva A. Venen-, Arterienkrankheiten, koronare Herzkrankheit bei Berufstätigen. Prospektiv-epidemiologische Untersuchungen Basler Studie I-III 1959-1978. Verlag Hans Huber; Bern- Stuttgart - Wien: 1981
  • 2 Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 1957; 17: 237-246
  • 3 Laurell CB. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 1966; 15: 45-52
  • 4 Meade TW, Chakrabarti R, Haines AP, North WR S, Stirling Y, Thompson SG, Brozovic M. Haemostatic function and cardiovascular death, early results of a prospective study. Lancet 1980; 1: 1050-1054
  • 5 Mettinger KL, Nyman D, Kjellin KG, Siden Å, Söderström CE. Factor VIII related antigen, antithrombin III, spontaneous platelet aggregation and plasminogen activator in ischemic cerebrovascular disease. J Neurol Sei 1978; 4: 31-38
  • 6 Christe M, Fritschi J, Lämmle B, Tran TH, Marbet GA, Berger W, Duckert F. Fifteen coagulation and fibrinolysis parameters in diabetes mellitus and in patients with vasculopathy. Thromb Haemostas 1984; 52: 138-143